Enlivex Therapeutics Ltd.
NASDAQ:ENLVBiotechnology
Healthcare
$4.26 +2.67%
+$0.19 today
- Market cap
- $71.70M
- Beta
- 1.52
- P/E (TTM)
- 0.0
- EPS (TTM)
- $407.81
52W Low $6.42High $31.50
Volume 0.06M
Average 0.44M
Price history
Enlivex Therapeutics Ltd. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-70.98%
Period high
$18.15
Period low
$4.20
Latest
$4.26
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 6-K | Jul 20, 2026 | Jul 20, 2026 | |
| 6-K | Jul 13, 2026 | Jul 13, 2026 | |
| 6-K | Jul 7, 2026 | Jul 7, 2026 | |
| 6-K | Jun 24, 2026 | Jun 24, 2026 | |
| 6-K | Jun 22, 2026 | Jun 22, 2026 | |
| 6-K | May 28, 2026 | May 28, 2026 | |
| 6-K | May 27, 2026 | May 27, 2026 | |
| 6-K | May 18, 2026 | May 18, 2026 | |
| 6-K | May 15, 2026 | May 15, 2026 | |
| 424B3 | May 1, 2026 | May 1, 2026 | |
| F-3 | Apr 21, 2026 | Apr 21, 2026 | |
| 6-K | Apr 21, 2026 | Apr 21, 2026 | |
| 6-K | Apr 8, 2026 | Apr 8, 2026 | |
| 6-K | Mar 26, 2026 | Mar 26, 2026 | |
| 20-F | Mar 25, 2026 | Mar 25, 2026 |
Competitors
Who does Enlivex Therapeutics Ltd. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about ENLV's filings, answered from its disclosures.
What is the latest ENLV filing?
The latest filing shown is 6-K dated Jul 20, 2026.
How many recent filings does ENLV have?
Intrinsic Alpha currently shows 20 recent filings for ENLV.
Continue the stock analysis
Jump to another research area for this company.